Drugs / SC599
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00210288 | May 2005 → Sep 2006 | shigellosis | Institut Pasteur | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SC599 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00210288 ↗ |
| Modality | Vaccine | “10^5 and 10^7 CFU of SC599 Oral Vaccine” NCT00210288 ↗ |
| Route | Oral | “SC599 Oral Vaccine” NCT00210288 ↗ |